Medicaments for the treatment of cerebral apoplexy

Details Medicaments for the treatment of cerebral apoplexy Medicaments for the treatment of cerebral apoplexy

1991-06-13

1992-10-13

Friedman, S. J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514646, A61K 31131, A61K 31335

Patent

active

051551284

ABSTRACT:
A method of treating cerebral apoplexy in a patient in need thereof which comprises administering to said patient an amount effective therefor of a serotonin agonist which has a binding strength of less than 10,000 nmol/l on binding to 5HT.sub.1A receptors.

REFERENCES:
patent: 5049588 (1991-09-01), Nicholson et al.
Journal of Neurology, Neurosurgery, and Psychiatry, Feb. 1981, vol. 44, No. 2.
Intensive Care Medicine, vol. 9, 1983, pp. 123-126.
Brain Research, vol. 435, No. 1-2, 1987, pp. 305-309.
Neurology, vol. 35, No. 4, Apr. 1985, pp. 584-587.
Chem. Abst.--112(1990) 211004y refer to 1988 Article.

Affiliated with

Also associated with

Rating

Medicaments for the treatment of cerebral apoplexy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicaments for the treatment of cerebral apoplexy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicaments for the treatment of cerebral apoplexy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1300727